| 1 |
28448568 | Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1. | 2017 |
1 |
| 2 |
27135197 | Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity. | 2016 Oct |
1 |
| 3 |
21543327 | Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. | 2011 Jul 15 |
3 |
| 4 |
20976277 | 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells. | 2010 Oct 14 |
3 |
| 5 |
19996280 | Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity. | 2009 Dec |
3 |
| 6 |
18066548 | Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. | 2008 Sep |
1 |
| 7 |
16540676 | 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. | 2006 Mar 15 |
2 |
| 8 |
15448016 | Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1. | 2004 Sep 15 |
2 |